[Ribosidation at N-3 of the silyl derivative of 6-chloro uracil. Preparation of 3-(beta-D-ribofuranosyl)-6-chloro uracil and of 3-(beta-D-ribofuranosyl) uracil ("isouridine")].

L. Pichat,G. Chatelain

1970-05-01

Abstract:

What problem does this paper attempt to address?

Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin

H. Brandwein,A. Deutsch,M. Thompson,R. Giannella

DOI: https://doi.org/10.1128/iai.47.1.242-246.1985

1985-01-01

Infection and Immunity

Abstract:In an effort to develop new approaches to the study and control of infectious diarrhea, we prepared murine monoclonal antibodies to the Escherichia coli heat-stable enterotoxin (STa). The toxin was purified from E. coli culture media and conjugated to bovine serum albumin. The STa-bovine serum albumin conjugate was used to immunize BALB/c mice, and the immune spleen cells from these mice were fused with SP2/0 myeloma cells. Resultant hybridomas were screened in an enzyme-linked immunosorbent assay protocol against 500 ng of STa-bovine serum albumin bound to microtiter wells as the solid-phase antigen. Five stable clones were selected and grown further in ascites fluid, which demonstrated anti-STa activity at dilutions of up to 1:500,000 in the enzyme-linked immunosorbent assay for heat-stable enterotoxin. In a competitive enzyme-linked immunosorbent assay format, the antibodies recognized several human and porcine strains of STa to various extents, but did not recognize E. coli heat-labile toxin, cholera toxin, or staphylococcal enterotoxin B. The antibodies were all able to bind lactoperoxidase-labeled [125I]STa, and antibody 20B3 was also able to dissociate [125I]STa bound to toxin receptors on rat jejunal villous cells. Preincubation of STa with antibodies 20B3 or 20F5 led to a concentration-dependent neutralization of toxin activity in a suckling mouse intestinal secretion assay. These antibodies are likely to provide new tools for the continued study of STa structure-function relationships and may lead to improved diagnosis and treatment of E. coli-induced infectious diarrhea.
The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Jie V Zhao,C Mary Schooling,Jia Xi Zhao

DOI: https://doi.org/10.1016/j.annepidem.2018.02.001

Abstract:Purpose: Observationally, homocysteine is associated with higher risk of diabetes. Folate, which reduces homocysteine, is promising for the prevention and treatment of diabetes. Previous meta-analysis of three trials suggested folate might lower hemoglobin A1c (HbA1c). Methods: An updated systematic review and meta-analysis of placebo-controlled randomized trials was conducted. We searched PubMed using ("folate" or "folic acid") and trial and ("glucose" or "diabetes" or "insulin" or "hemoglobin A1c" or "HbA1c") in any field until February 3, 2017. We also conducted a bibliographic search of selected studies and relevant reviews. Relative risk of diabetes and mean differences in indicators of glucose metabolism between folate and placebo were summarized in a meta-analysis using inverse variance weighting with random effects. Heterogeneity, publication bias, and risk of bias were also assessed. Results: Eighteen trials of 21,081 people with/without diabetes were identified. Folate decreased fasting glucose (-0.15 mmol/L, 95% confidence interval [CI] -0.29 to -0.01), homeostatic model assessment-insulin resistance (-0.83, 95% CI -1.31 to -0.34), and insulin (-1.94 μIU/mL, 95% CI -3.28 to -0.61) but had no clear effect on diabetes or HbA1c. Conclusions: Our study suggests a potential benefit of folate on insulin resistance and glycemic control; the latter requires examination in more high-quality trials.
452-P: Folic Acid on Homocysteine Levels in Type 2 Diabetes Patients—Systematic Review and Meta-analysis of Randomized Controlled Trials

KABELO O.S. MOKGALABONI,WENDY N. PHOSWA,RENEILWE G. MASHABA

DOI: https://doi.org/10.2337/db24-452-p

IF: 7.7

2024-06-14

Diabetes

Abstract:Introduction and objectives: The beneficial effect of folate has been observed in various conditions; however, the available evidence on homocysteine and reduction of cardiovascular disease (CVD) in type 2 diabetes (T2D) is limited. This study aims to quantitatively assess the effects of folate on homocysteine levels and the risk of CVDs in individuals with T2D. Methods: We comprehensively searched clinical trials from PubMed, Cochrane, and Scopus. The trials that focused on adult T2D using folate were included, while those with different interventions, T1D, and animal models of T2D were excluded. A random effect model was used due to heterogeneity. The data was analyzed using Jamovi 2.4.8. Results were presented as standardized mean differences (SMD) and 95% confidence intervals using forest plot. Results: Evidence retrieved from 9 studies with a sample size of 426 T2D patients was analyzed. Folate supplementation led to a significant reduction in homocysteine (SMD = -1.26 μmol/L, 95% CI: -1.74 to -0.78, p < 0.05) (Figure 1). The subgroup of the sample below 50 revealed no heterogeneity compared to a sample over 50. Conclusion: Our findings suggest that folate in T2D patients may reduce homocysteine and consequently mitigate CVD. Future trials should explore the effects of folate on homocysteine, especially using a large enough sample size. Disclosure K.O.S. Mokgalaboni: None. W.N. Phoswa: None. R.G. Mashaba: None.

endocrinology & metabolism
The effect of folic acid supplementation on body weight and body mass index: A systematic review and meta-analysis of randomized controlled trials

Alireza Jafari,Esmaeel Gholizadeh,Omidreza Sadrmanesh,Saeedeh Tajpour,Habib Yarizadeh,Behzad Zamani,Zahra Sohrabi

DOI: https://doi.org/10.1016/j.clnesp.2022.11.020

Abstract:Background and objective: Several trials have evaluated the effects of folate supplementation on obesity indices. However, their results were inconsistent. Therefore, the current meta-analysis was conducted to summarize data from available randomized clinical trials (RCTs) about the impact of folate supplementation on weight and body mass index (BMI). Method: Medline/PubMed, Scopus, Embase, and ISI web of science were searched to identify relevant articles up to December 2020. The effect sizes were expressed as weighted mean difference (WMD) and 95% confidence intervals (CI) using the random-effects model. Results: Pooled data from nine studies showed that folic acid supplementation did not change body weight (WMD: -0.16 kg, 95%CI: -0.47 to 0.16, P = 0.32) and BMI (WMD: -0.23 kg/m2, 95%CI: -0.49 to 0.03, P = 0.31), but there was significant heterogeneity between the included studies for BMI (I2 = 90.1%, P < 0.001). Moreover, subgroup analyses in level of homocysteine and health status indicated significant effect of folic acid supplementation on BMI in those with homocysteine level ≥15 μmol/L (WMD: -0.17 kg/cm2, -0.33 to -0.01, p = 0.03) and in women with polycystic ovary syndrome (PCOS) (WMD: - 0.30kg/cm2, -0.54 to -0.06, p = 0.01). Conclusion: Our outcomes demonstrated that folic acid improves BMI in those with homocysteine levels ≥15 μmol/L and women with PCOS.
Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis

Naghmeh Mirhosseini,Hassanali Vatanparast,Mohsen Mazidi,Samantha M Kimball

DOI: https://doi.org/10.1210/js.2017-00472

2018-05-25

Abstract:Diabetes prevention is a public health priority. Vitamin D supplementation may help prevent the development of diabetes in persons at increased risk. We performed a meta-analysis of controlled clinical trials that assessed glycemic outcome measures among adults at risk for type 2 diabetes, including prediabetes, overweight, or obesity. We searched PUBMED/ MEDLINE, CINAHL, and Google Scholar databases for trials published prior to April 2017. Placebo-controlled clinical trials with random allocation to vitamin D with or without calcium supplementation were selected. Data collection included country, study design, inclusion criteria, sample size, form, and dose of vitamin D, supplementation interval, control group, duration, participant characteristics, comorbidities, baseline and follow-up serum 25-hydroxyvitamin D [25(OH)D] concentration, and available outcome measures [glycosylated hemoglobin (HbA1c), fasting plasma glucose, plasma glucose after 2-hour oral glucose tolerance test, and homeostatic model assessment of insulin resistance (HOMA-IR)]. Data synthesis was conducted using random-effect models (PROSPERO registration no. CRD42017055326). Twenty-eight trials, representing 3848 participants, met the eligibility criteria. Compared with the control group, vitamin D supplementation significantly reduced HbA1c level by -0.48% (95% CI, -0.79 to -0.18), fasting plasma glucose level by -0.46 mmol/L (95% CI, -0.74 to -0.19), and HOMA-IR level by -0.39 (95% CI, -0.68 to -0.11). Subgroup analysis revealed that the effects of vitamin D supplementation on different glycemic measures were influenced by age, calcium coadministration, vitamin D deficiency, serum 25(OH)D level after supplementation, and duration of supplementation. Vitamin D supplementation and improved vitamin D status improved glycemic measures and insulin sensitivity and may be useful as part of a preventive strategy for type 2 diabetes.
Zinc Supplementation Improves Glycemic Control for Diabetes Prevention and Management: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Xinhui Wang,Wenhui Wu,Wanru Zheng,Xuexian Fang,Liyun Chen,Lothar Rink,Junxia Min,Fudi Wang

DOI: https://doi.org/10.1093/ajcn/nqz041

IF: 8.472

2019-01-01

American Journal of Clinical Nutrition

Abstract:Background: Although many studies have shown that low zinc status is associated with diabetes, the putative effects of zinc supplementation on glycemic control are inconclusive. Objectives: The aim of this meta-analysis of randomized controlled trials was to assess the effects of zinc supplementation in preventing and managing diabetes. Methods: PubMed, Embase, and the Cochrane Library were searched for articles that were published through February 10, 2019 and contained estimates for the outcomes of interest. The pooled results were then analyzed with the use of a random-effects model. Results: Thirty-two placebo-controlled interventions were extracted from 36 publications, involving a total of 1700 participants in 14 countries. Overall, compared with their respective control groups, the subjects in the zinc-supplementation group had a statistically significant reduction in fasting glucose [FG, weighted mean difference (WMD): -14.15 mg/dL; 95% CI: -17.36, -10.93 mg/dL], 2-h postprandial glucose (WMD: -36.85 mg/dL; 95% CI: -62.05, -11.65 mg/dL), fasting insulin (WMD: -1.82 mU/L; 95% CI: -3.10, -0.54 mU/L), homeostasis model assessment for insulin resistance (WMD: -0.73; 95% CI: -1.22, -0.24), glycated hemoglobin (WMD: -0.55%; 95% CI: -0.84, -0.27%), and high-sensitivity C-reactive protein (WMD: -1.31 mg/L; 95% CI: -2.05, -0.56 mg/L) concentrations. Moreover, subgroup analyses revealed that the effects of zinc supplementation on FG are significantly influenced by diabetic status and the formulation of the zinc supplement. Conclusions: Our analysis revealed that several key glycemic indicators are significantly reduced by zinc supplementation, particularly the FG in subjects with diabetes and in subjects who received an inorganic zinc supplement. Together, these findings support the notion that zinc supplementation may have clinical potential as an adjunct therapy for preventing or managing diabetes.
[Xenogeneic corneal grafting. I. Active and passive sensitizing of the rat against guinea pig cornea].

U. Gronemeyer,W. Müller‐ruchholtz

Abstract:
Gestational Diabetes Mellitus and Folic Acid Supplementation in Pregnant Women: A Systematic Review

Farah Stephanie,Albaini Obey,Jallad Karl,Stephanie Farah,Obey Albaini,Karl Jallad

DOI: https://doi.org/10.4236/jdm.2021.111003

2021-01-01

Journal of Diabetes Mellitus

Abstract:Background: Gestational diabetes mellitus (GDM) is a common pregnancy disorder screened for between the 24th and 28th weeks of gestation using oral glucose tolerance test. GDM has maternal and fetal health implications. Objective: To assess the relation between folic acid supplementation in pregnant women and the risk of developing GDM. Search Strategy: The search employed topic-based strategies designed for each database in June 2020. Databases searched were Pubmed, Cochrane Library, Embase and Lebanese American University online database. Selection Criteria: Studies eligible were those targeting the association of GDM development and folic acid supplementation, including pregnant women who have developed GDM and pregnant women who were on folic acid supplementation and developed GDM. Both interventional and observational studies were included. Data Collection and Analysis: Two reviewers extracted the data independently. A third reviewer checked the data for consistency and clarity. Data extracted included the sample characteristics, sample size and outcomes. Cohen’ s κ was used to assess agreement between reviewers. All tools and processes were piloted prior to use. Risk of bias was assessed using the Newcastle-Ottawa Scale. Data was presented in a tabulated form. Main Results: Six studies showed a proportional relation between folic acid intake and GDM, two reported a protective effect, and one cohort found no association. Conclusion: The inconsistent results made the formulation of a definitive conclusion difficult. Hence, larger studies are needed.
Effects of Folic Acid Supplementation on Oxidative Stress Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Omid Asbaghi,Matin Ghanavati,Damoon Ashtary-Larky,Reza Bagheri,Mahnaz Rezaei Kelishadi,Behzad Nazarian,Michael Nordvall,Alexei Wong,Frédéric Dutheil,Katsuhiko Suzuki,Amirmansour Alavi Naeini

DOI: https://doi.org/10.3390/antiox10060871

IF: 7.675

2021-05-28

Antioxidants

Abstract:(1) Background: This systematic review and meta-analysis aimed to assess the effects of folic acid supplementation on oxidative stress markers. (2) Methods: Online database including PubMed, Scopus, Web of Science, and Cochrane were searched up to January 2021, to retrieve randomized controlled trials (RCTs) which examined the effect of folic acid supplementation on markers of oxidative stress. Meta-analyses were carried out using a random-effects model. I2 index was used to evaluate the heterogeneity of RCTs. (3) Results: Among the initial 2322 studies that were identified from electronic databases search, 13 studies involving 1013 participants were eligible. Pooled effect size from 13 studies indicated that folic acid supplementation elicits a significant rise in serum concentrations of glutathione (GSH) (WMD: 219.01 umol/L, 95% CI 59.30 to 378.71, p = 0.007) and total antioxidant capacity (TAC) (WMD: 91.70 umol/L, 95% CI 40.52 to 142.88, p < 0.001) but has no effect on serum concentrations of nitric oxide (NO) (WMD: 2.61 umol/L, 95% CI −3.48 to 8.72, p = 0.400). In addition, folic acid supplementation significantly reduced serum concentrations of malondialdehyde (MDA) (WMD: −0.13 umol/L, 95% CI −0.24 to −0.02, p = 0.020). (4) Conclusions: This meta-analysis study suggests that folic acid supplementation may significantly improve markers within the antioxidative defense system by increasing serum concentrations of GSH and TAC and decreasing serum concentrations of MDA.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Effects of dietary supplementation in treatment and control of progression and complications of insulin-dependent diabetes mellitus: a systematic review with meta-analyses of randomized clinical trials

L.C. Ferraz,M.D.R. Barros,K.M.M. Almeida,M.B.G. Silva,N.B. Bueno

DOI: https://doi.org/10.1590/1414-431x2024e13649

2024-08-26

Brazilian Journal of Medical and Biological Research

Abstract:Ferraz, L.c. ; Barros, M.d.r. ; Almeida, K.m.m. ; Silva, M.b.g. ; Bueno, N.b. ; There is no safe and effective prevention for insulin-dependent diabetes (IDDM) mellitus, which makes it highly dependent on its treatment. This systematic review with meta-analyses of randomized clinical trials investigated the overall effects of dietary supplements of vitamins, minerals, trace elements, and non-essential compounds with antioxidant properties, fatty acids, and amino acids in IDDM. Searches of MEDLINE, Embase, CENTRAL, LILACS, The Grey Literature Report, and ClinicaTrials.gov, and citations from previous reviews were used to identify reports published through July 2023. The Risk of Bias 2 (RoB2) tool was used to analyze the risk of bias and GRADE was used to assess the quality of the results. Fifty-eight studies (n=3,044) were included in qualitative analyses and seventeen (n=723) in meta-analyses. Qualitative analyses showed few positive effects on some metabolic function markers, such as endothelial and renal function and lipid profile. Meta-analyses showed a positive effect of omega-3 on glycated hemoglobin (HbA1c) (RMD=-0.33; 95%CI: -0.53, -0.12, P=0.002; I2=0%; GRADE: low quality; 4 studies) and of vitamin D on fasting C-peptide (FCP) (RMD=0.05; 95%CI: 0.01, 0.9, P=0.023; I2=0%; GRADE: very low quality; 4 studies). Most studies showed bias concern or high risk of bias. A recommendation for dietary supplementation in IDDM cannot be made because of the few positive results within different interventions and markers, the serious risk of bias in the included studies, and the low quality of evidence from meta-analyses. The positive result of vitamin D on FCP is preliminary, requiring further investigation.

medicine, research & experimental,biology
Topologically novel multiple rotaxanes and catenanes based on tetraurea calix[4]arenes.

Anca Bogdan,Yuliya Rudzevich,M. Vysotsky,V. Böhmer

DOI: https://doi.org/10.1039/B601699E

IF: 4.9

2006-07-11

Chemical Communications

Abstract:Calix[4]arenes bearing at their wide rim four urea residues easily form hydrogen bonded dimeric capsules. This has been used to preorganise alkenyl functions attached to these urea groups for their controlled connection via metathesis reaction. Multimacrocyclic tetraurea derivatives are thus obtained in excellent yields via heterodimers which are formed exclusively with tetratosylurea derivatives. Heterodimerisation of such bis- and tetraloop tetraureas leads analogously to multicatenanes, or to rotaxanes by stoppering. Huge macrocycles are detached from tetraloop derivatives by cleavage of the urea function.
Use of a bacitracin mouthwash in dental caries control.

F. E. Law,D. Wallace,G. Spitz

DOI: https://doi.org/10.2307/4591381

1961-12-01

Abstract:TOPICAL fluoride applications have an effectiveness in inhibiting new dental caries that can be readily demonstrated (1-4). However, the topical technique has the major disadvantage of requiring substantial amounts of professional time for making the necessary applications. As a result the procedure is costly as a public health measure and not 'widely used by private dentists. The continuing search for a simplified and less costly dental caries preventive technique has led to consideration of other procedures and other solutions. A new method and another substance were suggested by studies of the effectiveness of a number of antibiotics in controlling oral lactobacilli (5-7) and in inliibiting dental caries (6,8). Penicillin and bacitracin were found equally effective in curbing dental decay in rats in an investigation in which antibiotics were mixed with selected decay-producing dietaries. The favorable results of these studies suggested the application of one of these antibiotics as a dental caries preventive in humans. Since the use of penicillin for this purpose is contraindicated because some individuals may develop sensitivity, bacitracin was the antibiotic of choice. In an exploratory study conducted among school children in Spotsylvania County, Va., in 1954-55, the relative efficacy of once daily use of mouthwashes of 100 ppm sodium fluoride by one group, 100 ppm sodium silicofluoride by another, and 250 units of zinc bacitracin per ounce by a tlhird group was tested and compared with findings of a control group using a solution of 100 ppm sodium chloride and a second control grotup who used no mouthwash. The negative findings of this study led to the conclusion that the antibiotic solution was not concentrated enough and the applications were not frequent enough to provide an effective anticaries procedure. Furtlhermore, tlhe fluoride solutions as applied in tlhis study did not provide significant caries control.
Effects of folic acid supplementation on liver enzymes, lipid profile, and insulin resistance in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Shadi Zarringol,Mohsen Taghizadeh,Fereshteh Bahmani,Abbas Mohtashamian,Armin Ebrahimzadeh,Nasrin Sharifi,MohamadReza Molaqanbari,HamidReza Talari

DOI: https://doi.org/10.4103/abr.abr_90_22

2023-04-28

Advanced Biomedical Research

Abstract:Background: Previous evidence revealed an association between folate deficiency and non-alcoholic fatty liver disease (NAFLD). This study is the first one investigating the effects of folic acid on hepatic steatosis grade, liver enzymes, insulin resistance, and lipid profile in NAFLD cases. Materials and Methods: Sixty-six participants with NAFLD were allocated randomly to take either a placebo or one oral tablet of folic acid (1 mg) on a daily basis within eight weeks. Serum folate, homocysteine, glucose, aminotransferases, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and lipids were assessed. Ultrasonography was used for assessing the liver steatosis grade. Results: The serum alanine transaminase, grade of hepatic steatosis, and aspartate transaminase significantly were decreased within both study groups; however, the between-group comparison was not statistically significant. Of note, the decrease in ALT was more pronounced in folic acid compared with the placebo group (-5.45 ± 7.45 vs. -2.19 ± 8.6 IU/L). The serum homocysteine was decreased after receiving folic acid compared to the placebo (-0.58 ± 3.41 vs. +0.4 ± 3.56 μmol/L; adjusted P = 0.054). Other outcomes did not significantly change. Conclusion: Supplementation with folic acid (1 mg/d) for eight weeks among cases with NAFLD did not change significantly the serum levels of liver enzymes, the hepatic steatosis grade, insulin resistance and lipid profile. However, it was able to prevent the increase in homocysteine in comparison with the placebo. Conducting further research is suggested with the longer duration and different doses of folic acid, adjusted to the genotypes of methylenetetrahydrofolate reductase polymorphism, among NAFLD patients.
Sulphonylurea therapy and hypothyroidism.

R. Prince,G. K. Worth,G. Shenfield

Abstract:
Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide

Nan Zhang,Ziyi Zhou,Xiying Chi,Fangfang Fan,Shuqun Li,Yun Song,Yan Zhang,Xianhui Qin,Ningling Sun,Xiaobin Wang,Yong Huo,Jianping Li

DOI: https://doi.org/10.1016/j.clnu.2024.05.034

Abstract:Background & aims: The AHA/ASA guidelines for primary stroke prevention are almost a decade old. The current recommendation regarding folic acid supplementation is based on only 8 clinical trials, and an additional 13 folate trials have been published since then. This meta-analysis aims to fill in critical evidence gaps by comprehensively evaluating 21 published trials with particular attention given to identifying the true influences through stratification. Methods: PubMed, the Cochrane Central Register of Controlled Trials, and Embase were searched from inception to April 4, 2023. This study included all randomized controlled trials (RCTs) of folic acid with stroke as one of the reporting endpoints. Relative risks and 95% confidence intervals were used to assess the association between folic acid supplementation and the risk of stroke in a random-effects model. Results: Results from the 21 pooled RCTs totaling 115,559 participants showed that folic acid supplementation significantly reduced the risk of stroke by 10% (RR 0.90, 95%CI 0.83 to 0.98). Subgroup analyses showed that folic acid efficacy was greater in areas without fortified grain or with partially-fortified grain (RR = 0.83, 95% CI 0.75 to 0.93; RR = 1.04 in areas with grain fortification, P-interaction = 0.003). In this group, folic acid supplementation was most efficacious in those without a history of stroke or myocardial infarction (RR = 0.77, 95% CI 0.68 to 0.86; RR = 0.94 for participants with a history of stroke or myocardial infarction, P-interaction = 0.008). The efficacy of folic acid remained consistent regardless of baseline folate levels, folic acid dosage, baseline vitamin B12 levels, vitamin B12 dosage, homocysteine reduction, intervention duration, and whether folic acid was taken alone or in combination (all P-interaction>0.05). All 21 trials were free of attrition bias and reporting bias, and there was no significant publication bias. Conclusions: This is by far the largest meta-analysis of RCTs regarding folic acid supplementation and stroke, demonstrating the overall benefit of folic acid for stroke prevention. Grain fortification and history of stroke or myocardial infarction may be the most important influences on the efficacy of folic acid for stroke prevention.
The Effect of Vitamin D Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: An Updated Systematic Review and Meta‐Analysis of Clinical Trials

Maryam Afraie,Pourya Bahrami,Parisa Kohnepoushi,Sorour Khateri,Lobat Majidi,Lotfollah Saed,Kamran Zamani,Hedyeh Mohammadi Baharm,Yousef Moradi,Farhad Moradpour

DOI: https://doi.org/10.1155/2024/9960656

IF: 4.0608

2024-09-11

Journal of Diabetes Research

Abstract:Background and Aims: The purpose of this meta‐analysis was to investigate the effect of vitamin D supplementation on hemoglobin A1C (HbA1C), fasting blood sugar (FBS), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL), systolic blood pressure (SBP), and the total vitamin D level in patients with Type 2 diabetes (T2DM). Methods: A systematic search was conducted in databases such as PubMed (Medline), Scopus, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov using relevant keywords from January 1990 to January 2024. After screening and extracting data, a qualitative evaluation of articles was performed using the Cochrane risk‐of‐bias tool for randomized trials (RoB 2). Results: The findings revealed that vitamin D supplementation significantly decreased the mean HbA1C (SMD: −0.15; 95% CI: −0.29, −0.20; I square : 79.76%; p value < 0.001) and mean FBS (SMD: −0.28; 95% CI: −0.40, −0.15; I square : 70.13%; p value < 0.001), lowered SBP (SMD: −0.06; 95% CI: −0.16, −0.05; I square : 39.63%; p value = 0.23), and reduced LDL (SMD: −0.11; 95% CI: −0.28, −0.05; I square : 73.66%; p value < 0.001). Furthermore, vitamin D supplementation increased the average HDL (SMD: 0.13; 95% CI: 0.04, 0.29; I square : 79.33%; p value < 0.001) and vitamin D levels (SMD: 1.78; 95% CI: 1.53, 2.04; I square : 91.92%; p value < 0.001) in patients with T2DM. Subgroup analyses showed that weight gain, BMI, and duration of the disease could reduce the effect of vitamin D supplementation on diabetes control in affected patients. Conclusion: The results also indicated that taking vitamin D supplements in the amount of 50,000 IU had a significant effect on reducing the indicators related to diabetes control. Based on the combined evidence, the findings of this meta‐analysis suggest that vitamin D supplementation can significantly improve glycemic control and reduce the risk of complications associated with T2DM, especially cardiovascular diseases (CVDs).

endocrinology & metabolism,medicine, research & experimental
Significance of Enamel Remineralization

W. Briner,J. Gray,M. Francis

DOI: https://doi.org/10.1177/00220345740530021101

1974-03-01

Abstract:In this discussion we propose that remineralization is a real phenomenon, occurring in vitro and in vivo. The frequency with which it occurs in the human mouth, however, still needs further documentation. Remineralization experiments with natural and artificial "white spots" will be reviewed with emphasis on the role of diffusion channels. Evidence from studies on "maturation" (posteruptive) of rat molars and a discussion of how maturation is related to both demineralization (caries) and remineralization also will be presented. In this discussion remineralization is defined as the repair of enamel after caries attack.' This definition implies cessation of caries activity and deposition of mineral in the damaged area. Therefore, to effect remineralization' one should not only have knowledge of the caries attack and be able to reduce it, but also have knowledge of mineralization that occurs in areas of hypomineralization.
Association of Folic Acid Supplementation in Early Pregnancy with Risk of Gestational Diabetes Mellitus: A Longitudinal Study

Hongyan Chen,Yaqiong Hu,Yannan Li,Wenzheng Zhou,Niya Zhou,Huan Yang,Qing Chen,Yawen Li,Qiao Huang,Zhen Chen

DOI: https://doi.org/10.3390/nu14194061

IF: 5.9

2022-09-30

Nutrients

Abstract:Background: Gestational diabetes mellitus (GDM) may lead to many adverse effects on women and their offspring. Method: 24,429 pregnant women were enrolled during early pregnancy from January 2018 to December 2021. The self-reported intake of folic acid supplements was assessed via a questionnaire. Oral glucose tolerance tests were used for the diagnosis of GDM. The association between intake or not, dose, and duration of folic acid and GDM risk was assessed. Results: 6396 (26.18%) women were diagnosed with GDM. In the univariate models, folic acid was found to be correlated with total GDM risk (OR = 0.82, 95% CI: 0.70~0.95, p = 0.009). After adjusting for potential confounders, the association with total GDM risk was not significant, but the association of folic acid with 2-h PBG diagnosed GDM risk was consistently significant (OR = 0.75, 95% CI: 0.63~0.90, p = 0.002). No significant association between the dose and duration of folic acid supplementation and GDM risk was observed in the analyses. Conclusion: Folic acid supplementation might be a protective factor for the risk of GDM caused by the high level of postprandial blood glucose, but the dose or duration-related association between folic acid supplementation and GDM risk is not clear.

nutrition & dietetics

[Ribosidation at N-3 of the silyl derivative of 6-chloro uracil. Preparation of 3-(beta-D-ribofuranosyl)-6-chloro uracil and of 3-(beta-D-ribofuranosyl) uracil ("isouridine")].

Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin

The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

452-P: Folic Acid on Homocysteine Levels in Type 2 Diabetes Patients—Systematic Review and Meta-analysis of Randomized Controlled Trials

The effect of folic acid supplementation on body weight and body mass index: A systematic review and meta-analysis of randomized controlled trials

Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis

Zinc Supplementation Improves Glycemic Control for Diabetes Prevention and Management: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

[Xenogeneic corneal grafting. I. Active and passive sensitizing of the rat against guinea pig cornea].

Gestational Diabetes Mellitus and Folic Acid Supplementation in Pregnant Women: A Systematic Review

Effects of Folic Acid Supplementation on Oxidative Stress Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of dietary supplementation in treatment and control of progression and complications of insulin-dependent diabetes mellitus: a systematic review with meta-analyses of randomized clinical trials

Topologically novel multiple rotaxanes and catenanes based on tetraurea calix[4]arenes.

Use of a bacitracin mouthwash in dental caries control.

Effects of folic acid supplementation on liver enzymes, lipid profile, and insulin resistance in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Sulphonylurea therapy and hypothyroidism.

Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide

The Effect of Vitamin D Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: An Updated Systematic Review and Meta‐Analysis of Clinical Trials

Significance of Enamel Remineralization

Association of Folic Acid Supplementation in Early Pregnancy with Risk of Gestational Diabetes Mellitus: A Longitudinal Study